Lifestar Pharma Llcc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Lifestar Pharma Llcc Pharmaceutical Import Records from India — 3 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Lifestar Pharma Llcc — Pharmaceutical Importer Profile (2026) | 3 Products, $1.3M Trade | TransData Nexus

Lifestar Pharma Llcc

Pharmaceutical Importer · United States · Respiratory Focus · $1.3M Total Trade · DGFT Verified

Lifestar Pharma Llcc is a pharmaceutical importer based in United States with a total trade value of $1.3M across 3 products in 3 therapeutic categories. Based on 25 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Lifestar Pharma Llcc sources from 1 verified Indian supplier, with Mankind Pharma Limited accounting for 100.0% of imports.

Lifestar Pharma Llcc — Import Portfolio & Supplier Network

Lifestar Pharma Llcc import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Lifestar Pharma Llcc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mankind Pharma Limited	$6.0M	288	100.0%

Lifestar Pharma Llcc sources from 1 verified Indian supplier across 188 distinct formulations. The sourcing is highly concentrated — Mankind Pharma Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Lifestar Pharma Llcc Import?

Formulation	Value	Ships
Tobramycin inhalation solution, USP 300MG/5 ML 56x5ml ( qty.972 packs) net conent of 16.3296 kg of bulk drug) batch	$150.0K	3
Tobramycin inhalation solution, USP 300MG/5 ML 56x5ml (qty.1296 packs) net conent 21.7728 kg of bulk drug) batch no.	$150.0K	3
Ttobramycin inhalation solution USP 300MG/4 ML ( qty.492 packs) net conent of8.2656 kg of bulk drug) batch no.	$150.0K	3
Formoterol fumarate inhalation solution,20mcg/2ML 60x2ml ( qty.3648 packs) netconent of 4.60 GM of bulk drug)	$150.0K	3
Tobramycin inhalation solution, USP 300MG/4 ML ( qty.515 packs) net conent of 9.40905 kgs of bulk drug)	$150.0K	3
Tobramycin inhalation solution, USP 300MG/5 ML 56x5ml ( qty.1447 packs) net conent of 26.254368 kgs of bulk drug)	$150.0K	3
Phenylephrine hcl oph. soln., USP, 10% batch no. c4x004 mfg. date mar-2024 exp date	$150.0K	3
Phenylephrine hcl oph. soln., USP, 10% batch no. c4x003 mfg. date mar-2024 exp date	$150.0K	3
Formoterol fumarate inhalation solution,20mcg( qty.3656 packs) net conent of 4.61 grmof bulk drug) batch no.	$150.0K	3
Formoterol fumarate inhalation solution,20mcg/2ML ( qty.3742 packs) net conentof 4.71 grmof bulk drug)batch no.	$150.0K	3
Ttobramycin inhalation solution USP 300MG/5 ML 56x5ml ( qty.648 packs) net conent of 10.8864 kg of bulk drug) batch	$128.4K	3
Baclofen tablets USP 20MG 100s batch no da4y001 mfg date apr 2025 exp date mar	$116.8K	3
Arformoterol tartrate inhalation solution 15 MCG/2 ML (0.015 MG/2 ML) 60x2ml sterile unit-dose vials (15x4 unit dose	$100.0K	2
Lansoprazole delayed release capsules 30MG 90s batch no a2ioy001 mfg date mar 2025 exp date feb	$86.0K	2
Midodrine hydrochloride tablets USP 5 MG 100 ct net content 3 972	$71.5K	3

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Formoterol	Respiratory	$800.0K	16	1.4%	10
2	Phenylephrine	Respiratory & OTC	$350.0K	7	0.4%	13
3	Nitrofurantoin	Advanced Antibiotics	$100.0K	2	0.3%	18

Lifestar Pharma Llcc imports 3 pharmaceutical products across 3 categories into United States totaling $1.3M.

Lifestar Pharma Llcc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Lifestar Pharma LLC is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from international suppliers. Established as a subsidiary of Mankind Pharma Limited in 2016, Lifestar Pharma operates with a focus on delivering affordable, high-barrier generic medicines across diverse dosage forms, including ophthalmics, injectables, inhalation solutions, and oral solids.

Headquartered in Mahwah, New Jersey, Lifestar Pharma plays a pivotal role in the United States pharmaceutical distribution network by sourcing and importing a wide array of generic medications. This strategic positioning enables the company to enhance the accessibility and affordability of essential medicines within the U.S. market. The partnership with Mankind Pharma Limited, India's fourth-largest pharmaceutical company, underscores Lifestar Pharma's commitment to leveraging global manufacturing capabilities to meet domestic healthcare needs.

2Distribution Network

Lifestar Pharma LLC's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across the United States. While specific warehouse locations are not publicly disclosed, the company's operations are supported by a robust logistics framework that facilitates timely and reliable distribution. This infrastructure is crucial for maintaining the integrity and availability of the imported pharmaceutical formulations.

The company's geographic coverage spans the entire U.S., ensuring that a diverse range of healthcare providers and patients have access to its imported generic medicines. By leveraging its distribution capabilities, Lifestar Pharma effectively addresses the demand for affordable and high-quality pharmaceuticals nationwide.

3Industry Role

In the United States pharmaceutical supply chain, Lifestar Pharma LLC functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, the company plays a critical role in enhancing the availability of generic medications within the U.S. market. This position allows Lifestar Pharma to contribute to the diversification of the pharmaceutical supply chain, offering healthcare providers and patients access to a broader spectrum of affordable treatment options.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Lifestar Pharma Llcc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Lifestar Pharma LLC's sourcing strategy exhibits a high degree of concentration, with a total import value of $1.3 million USD from India over 25 shipments, all sourced from a single supplier, Mankind Pharma Limited. This single-source dependency indicates a strategic choice aimed at ensuring consistency and quality in the imported products. Mankind Pharma's extensive portfolio, encompassing over 500 products across various therapeutic areas, provides Lifestar Pharma with a comprehensive range of options to meet diverse market demands.

The shipment data reveals a stable and ongoing relationship between Lifestar Pharma and Mankind Pharma, suggesting a reliable supply chain. However, this concentration also presents potential risks, such as supply disruptions or changes in supplier dynamics. To mitigate these risks, Lifestar Pharma may consider diversifying its supplier base or establishing contingency plans to ensure uninterrupted access to essential pharmaceutical formulations.

2Supply Chain Resilience

Lifestar Pharma LLC's supply chain resilience is closely tied to its partnership with Mankind Pharma Limited. Mankind Pharma's manufacturing facilities are strategically located across India, including Himachal Pradesh, Uttarakhand, Sikkim, and Maharashtra, and are equipped with state-of-the-art technology adhering to rigorous quality control standards.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces regulations that ensure the safety, efficacy, and quality of drugs entering the U.S. market.

Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which provides the legal framework for drug approval and regulation. The Drug Enforcement Administration (DEA) also plays a role in regulating controlled substances. For Indian generics to be marketed in the U.S., they must undergo the FDA's Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are stringent. Manufacturers must obtain FDA approval for each product, which involves submitting an ANDA that includes data on the drug's composition, manufacturing process, and bioequivalence studies.

Good Manufacturing Practice (GMP) certification is essential for ensuring product quality. The FDA recognizes GMP certifications from reputable international bodies, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Manufacturers must adhere to these standards to gain approval for the U.S. market.

Lifestar Pharma Llcc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Lifestar Pharma LLC's product strategy focuses on importing high-barrier generic medicines across therapeutic areas such as respiratory, advanced antibiotics, and over-the-counter (OTC) products. This focus aligns with the company's mission to provide affordable and accessible healthcare solutions.

The market demand for these therapeutic areas is driven by the prevalence of respiratory conditions, the need for effective antibiotics, and the growing consumer preference for OTC medications. By concentrating on these segments, Lifestar Pharma addresses critical healthcare needs while maintaining a competitive edge in the U.S. market.

2Sourcing Profile

Lifestar Pharma LLC's sourcing strategy is centered on acquiring generic drugs from Mankind Pharma Limited, emphasizing formulations that meet the FDA's standards for bioequivalence and quality. This approach ensures that the imported products are suitable for the U.S. market and align with the company's commitment to affordability and accessibility.

India's role in Lifestar Pharma's procurement is significant, given the country's robust pharmaceutical manufacturing capabilities and adherence to international quality standards. This partnership enables Lifestar Pharma to offer a diverse range of high-quality generic medications to the U.S. market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Lifestar Pharma Llcc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Lifestar Pharma LLC, provided they can meet the FDA's stringent requirements for bioequivalence, quality, and manufacturing practices. Gaps in Lifestar Pharma's current sourcing may exist in specific therapeutic areas or dosage forms, presenting potential avenues for collaboration.

Indian exporters seeking to become alternative suppliers should focus on demonstrating compliance with international quality standards, the ability to meet the specific needs of the U.S. market, and a commitment to affordability and accessibility.

2Requirements & Qualifications

Indian exporters aiming to supply Lifestar Pharma LLC and the U.S. market must obtain FDA approval for each product, which involves submitting

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Lifestar Pharma Llcc

What products does Lifestar Pharma Llcc import from India?

Lifestar Pharma Llcc imports 3 pharmaceutical products across 3 categories. Top imports: Formoterol ($800.0K), Phenylephrine ($350.0K), Nitrofurantoin ($100.0K).

Who supplies pharmaceuticals to Lifestar Pharma Llcc from India?

Lifestar Pharma Llcc sources from 1 verified Indian suppliers. The primary supplier is Mankind Pharma Limited (100.0% of imports, $6.0M).

What is Lifestar Pharma Llcc's total pharmaceutical import value?

Lifestar Pharma Llcc's total pharmaceutical import value from India is $1.3M, based on 25 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Lifestar Pharma Llcc focus on?

Lifestar Pharma Llcc imports across 3 categories. The largest: Respiratory (64.0%), Respiratory & OTC (28.0%), Advanced Antibiotics (8.0%).

Get Full Lifestar Pharma Llcc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.